Hello and Welcome to Patientsville.com, Your Source for all PHENERGAN information. We are dedicated to provide You with PHENERGAN safety information. Learn about PHENERGAN serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
PHENERGAN Safety Reports
Total PHENERGAN reports: 36.PHENERGAN FDA safety alerts: 2005 2006 .
Reported deaths: 7 Reported hospitalizations: 9.
Take PHENERGAN Side Effects Survey or Share Your PHENERGAN Story. Read More Here.
Consumer or non-health professional from UNITED STATES reported PHENERGAN problem on Jan 11, 2007. Male patient, 35 years of age, weighting 155.0 lb, was diagnosed with nausea and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: impaired work ability, injection site irritation, injection site pain, thrombophlebitis superficial. PHENERGAN dosage: unknown. Patient recovered.
PHENERGAN problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 16, 2007. Female patient, 75 years of age, weighting 110.0 lb, was diagnosed with nausea, vomiting and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: aphasia, speech disorder. PHENERGAN dosage: unknown. Patient recovered.
Pharmacist from UNITED STATES reported PHENERGAN problem on Jan 19, 2007. Female patient, weighting 89.60 lb, was diagnosed with nausea and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, respiratory distress. PHENERGAN dosage: 25 MG ONCE IV BOLUS. Patient recovered.
PHENERGAN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Male patient, 79 years of age, weighting 173.9 lb, was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: dystonia. PHENERGAN dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported PHENERGAN problem on Apr 09, 2007. Male patient, 27 years of age, weighting 186.3 lb, was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: muscle spasms. PHENERGAN dosage: unknown. Patient recovered.
PHENERGAN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 27, 2007. Female patient, 35 years of age, was diagnosed with nausea, vomiting, breast cancer and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: chills, dyspnoea, muscle twitching. PHENERGAN dosage: unknown. During the same period patient was treated with GEMZAR, TAXOL, COMPAZINE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported PHENERGAN problem on May 18, 2007. Female patient, 75 years of age, weighting 126.0 lb, was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, loss of consciousness, speech disorder. PHENERGAN dosage: unknown. Patient recovered.
PHENERGAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2006. Female patient, child 7 years of age, was diagnosed with gastroenteritis viral, vomiting and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: accidental overdose, coma, convulsion, cyanosis, dyspnoea, loss of consciousness, respiratory arrest, respiratory distress. PHENERGAN dosage: unknown. During the same period patient was treated with CHLOROMYCETIN. Patient was hospitalized. Patient died on 01/01/1962.
Pharmacist from UNITED STATES reported PHENERGAN problem on Aug 24, 2006. Male patient, 82 years of age, weighting 150.6 lb, was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: neuroleptic malignant syndrome. PHENERGAN dosage: 25 MG IV. Patient was hospitalized. Patient recovered.
PHENERGAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2006. Male patient, weighting 28.66 lb, was diagnosed with viral infection and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: no adverse effect. PHENERGAN dosage: 12.5 MG. ONCE IV. Patient recovered.
Consumer or non-health professional from UNITED STATES reported PHENERGAN problem on Aug 28, 2006. Female patient, 24 years of age, weighting 110.0 lb, was diagnosed with nausea, vomiting and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: crying, infusion site pain, pain in extremity, phlebitis, screaming, sensation of pressure. PHENERGAN dosage: unknown. Patient recovered.
PHENERGAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2006. Female patient, 55 years of age, weighting 146.0 lb, was diagnosed with nausea and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: contusion, infection, infusion site pain, oedema peripheral, paraesthesia, skin discolouration, thrombophlebitis superficial, vein disorder. PHENERGAN dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported PHENERGAN problem on Aug 30, 2006. Female patient, 55 years of age, weighting 148.0 lb, was diagnosed with nausea and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: contusion, infection, infusion site pain, oedema peripheral, paraesthesia, skin discolouration, thrombophlebitis superficial, vein disorder. PHENERGAN dosage: unknown. Patient recovered.
PHENERGAN problem was reported by a Pharmacist from UNITED STATES on Sept 21, 2006. Male patient, 40 years of age, was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: restless legs syndrome. PHENERGAN dosage: 20 MG X1 IV. Patient recovered.
Pharmacist from UNITED STATES reported PHENERGAN problem on Sept 27, 2006. Male patient, 23 years of age, weighting 146.4 lb, was diagnosed with vomiting and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: cellulitis, thrombophlebitis, vomiting. PHENERGAN dosage: 12.5 MG ONCE IVP. Patient recovered.
PHENERGAN problem was reported by a Pharmacist from UNITED STATES on Sept 27, 2006. Female patient, 64 years of age, was diagnosed with dizziness, nausea, vomiting and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: cellulitis, erythema, oedema peripheral. PHENERGAN dosage: 25 MG ONCE IV. Patient recovered.
Pharmacist from UNITED STATES reported PHENERGAN problem on Sept 27, 2006. Female patient, 39 years of age, weighting 120.2 lb, was diagnosed with migraine and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: thrombophlebitis. PHENERGAN dosage: 12.5 MG ONCE IV. Patient recovered.
PHENERGAN problem was reported by a Pharmacist from UNITED STATES on Sept 27, 2006. Male patient, weighting 200.0 lb, was diagnosed with nausea and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, pain in extremity, thrombophlebitis superficial. PHENERGAN dosage: 12.5 MG Q6H PRN IV X 2 DOSES. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported PHENERGAN problem on Sept 20, 2006. Female patient, 79 years of age, weighting 116.1 lb, was diagnosed with vomiting and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome. PHENERGAN dosage: unknown. During the same period patient was treated with LASIX, ALBUTEROL. Patient died on 08/08/2006.
PHENERGAN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 13, 2006. Male patient, 42 years of age, weighting 223.0 lb, was diagnosed with nausea and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, injection site erythema, injection site irritation, injection site thrombosis. PHENERGAN dosage: 25 MG ONCE IV PUSH IN WRIST. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported PHENERGAN problem on Oct 18, 2006. Female patient, 85 years of age, weighting 125.0 lb, was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: amnesia, dementia, hallucination, loss of consciousness, mental disorder. PHENERGAN dosage: unknown. Patient was hospitalized. Patient recovered.
PHENERGAN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 02, 2006. Male patient, weighting 30.00 lb, was diagnosed with cough and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, breath sounds abnormal, complex partial seizures, convulsion, depressed level of consciousness, dyspnoea, educational problem, eye rolling, febrile convulsion. PHENERGAN dosage: unknown. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported PHENERGAN problem on Nov 14, 2006. Female patient was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: burning sensation, cellulitis, contusion, erythema, hypoaesthesia, oedema peripheral, pain. PHENERGAN dosage: INJECTABLE AMPUL 25MG/ML. Patient recovered.
PHENERGAN problem was reported by a Pharmacist from UNITED STATES on Nov 14, 2006. Female patient was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: burning sensation, injection site irritation, injection site swelling, pain. PHENERGAN dosage: AMPUL 25 MG/ML INJECTABLE. Patient recovered.
Pharmacist from UNITED STATES reported PHENERGAN problem on Nov 14, 2006. Female patient, 32 years of age, was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: erythema, finger amputation, gangrene, iatrogenic injury, infusion site pain, local swelling, peripheral coldness, rash macular. PHENERGAN dosage: unknown. Patient recovered.
PHENERGAN problem was reported by a Physician from UNITED STATES on Nov 01, 2006. Female patient, 19 years of age, was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: intentional overdose. PHENERGAN dosage: unknown. During the same period patient was treated with COCAINE, METHADONE. Patient died on 01/01/2005.
Consumer or non-health professional from UNITED STATES reported PHENERGAN problem on Nov 01, 2006. Female patient, 19 years of age, was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: intentional overdose. PHENERGAN dosage: unknown. During the same period patient was treated with COCAINE, METHADONE. Patient died on 01/01/2005.
PHENERGAN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2006. Female patient, 28 years of age, was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: intentional overdose. PHENERGAN dosage: unknown. During the same period patient was treated with COCAINE, METHADONE. Patient died on 01/01/2005.
Consumer or non-health professional from UNITED STATES reported PHENERGAN problem on Nov 29, 2006. Female patient, 83 years of age, weighting 89.00 lb, was diagnosed with nausea, vomiting and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: arm amputation, arterial spasm, gangrene, poor peripheral circulation. PHENERGAN dosage: 12.5 MG INTRA-ARTER. Patient was hospitalized. Patient recovered.
PHENERGAN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 27, 2006. Female patient, 58 years of age, weighting 110.0 lb, was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, blood alkaline phosphatase increased. PHENERGAN dosage: 25 MG PRN Q6H. During the same period patient was treated with ZOFRAN, NEULASTA, LEXAPRO, POTASSIUM CHLORIDE, LASIX, TOPROL, LORTAB. Patient died on 11/13/2006.
Consumer or non-health professional from UNITED STATES reported PHENERGAN problem on Dec 06, 2006. Male patient, 48 years of age, weighting 194.7 lb, was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: rash. PHENERGAN dosage: unknown. Patient recovered.
PHENERGAN problem was reported by a Pharmacist from UNITED STATES on July 02, 2007. Female patient, 72 years of age, weighting 174.2 lb, was diagnosed with nausea, vomiting and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: asthenia, body temperature increased, cough, dehydration, depressed level of consciousness, extrapyramidal disorder, lethargy, pain, restlessness. PHENERGAN dosage: 12.5MG IV SLOW PUSH X1. During the same period patient was treated with ENALAPRIL, ARICEPT, ASPIRIN, VIT B, PLAVIX, METFORMIN, TRAMADOL. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported PHENERGAN problem on July 13, 2007. Female patient was diagnosed with nausea and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: foetal growth retardation. PHENERGAN dosage: unknown. Patient died on 07/01/2007.
PHENERGAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 23, 2007. Female patient, 29 years of age, weighting 130.1 lb, was diagnosed with nausea, pain and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: arterial injury, gangrene, hypoaesthesia, infusion site pain, pain in extremity, postoperative wound infection. PHENERGAN dosage: unknown. During the same period patient was treated with DILAUDID, CHLORIDE. Patient was hospitalized and became disabled. Patient recovered.
Health Professional from UNITED STATES reported PHENERGAN problem on Sept 11, 2007. Male patient, 31 years of age, weighting 187.5 lb, was diagnosed with abdominal pain and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: rash, urticaria. PHENERGAN dosage: unknown. Patient recovered.
PHENERGAN problem was reported by a Physician from UNITED STATES on Sept 18, 2007. Female patient, weighting 145.0 lb, was diagnosed with migraine, nausea and was treated with PHENERGAN. After drug was administered, patient experienced the following problems/side effects: erythema, fasciitis, injection site discolouration, injection site reaction, injection site swelling, injection site warmth, myositis, pain in extremity, pyrexia. PHENERGAN dosage: unknown. During the same period patient was treated with TORADOL, BENADRYL, TOPAMAX, STADOL, PHRENALIN. Patient recovered.